Led · Series B · May 2024

ifeel began in 2017 as a consumer-focused therapy platform and pivoted during the pandemic to let businesses and insurance providers offer staff mental-health support. Its core product starts with a digital assessment that functions as a co-pilot to an AI system, evaluating user risk and recommending appropriate levels of care. The platform recommends treatments ranging from mild interventions up to high-risk case pathways, with the stated goal of identifying high-risk users early to prevent serious impact. ifeel is offered as part of employers' or insurance providers' healthcare cover and competes with companies like Modern Health. Leadership describes the product as designed to help companies provide scalable, preventative mental-health support for employees. Financially, the company has raised a $20 million Series B and $40 million in total funding to date, after a prior $6.6 million raise in 2021. ifeel provides an annual emotional support plan for companies combining prevention, monitoring, digital exercises and access to specialized therapists via web and iOS/Android apps. The platform gives HR teams aggregate anonymous analytics on psychosocial risk factors and prevention resources. ifeel leverages AI and more than 10 million data points to screen, triage and prioritize users and to personalize experiences through hundreds of clinical tools and AI-enhanced recommendations. Individual users can access articles, an emotions diary, audio guides, relaxation/meditation tools, and direct sessions with professional psychologists, including online therapy. Founded in 2017 and based in Madrid, the service covers 23 countries in 21 languages and has over 800,000 users and 600 therapists. Customers include AXA Partners, SCOR SE, Glovo, Travelperk, Gympass, Thoughtworks and González Byass. ifeel delivers live therapy sessions with licensed psychologists alongside self-care features such as daily mood trackers, recommended exercises and personalized content. The platform uses AI to recommend the most relevant self-care content and is exploring AI tools to assist therapists within the practice. Founded in 2017, the company pivoted last year from a consumer-only model to a hybrid B2B/B2C approach to serve employers and insurance partners. That pandemic-driven pivot produced 1,000% growth in its B2B business and has led to partnerships with companies including AXA Partners, Glovo and Gympass. ifeel reports 400,000 total users across B2C and B2B, with 100,000 eligible users covered via partners and employees of about 100 companies using the service weekly. Its main markets so far are Spain, France, Brazil and Mexico, while its B2B and insurance network covers 20 countries and supports four languages (English, Spanish, French and Portuguese).

Led · Series B · Mar 2023

Assured Allies is an insurtech focused on retirement savings and long-term care solutions that combines machine learning, predictive analytics, science-of-aging and human support. The company was founded in 2018 by Roee Nahir and Dr. Afik Gal and launched its first product, AgeAssured, in 2020 to partner with long-term care insurers and support aging-at-home. AgeAssured has been shown to reduce the cost of long-term insurance claims by roughly 20%. In 2022 Assured Allies introduced NeverStop, which uses artificial intelligence and science to create and underwrite retirement products. The business saw 300% growth in the number of members using its platform and secured partnerships with several leading long-term care insurance carriers over the prior year. Financially, it closed a $42.5M Series B and has now raised $65M in total capital. Management intends to deploy the new capital into further product growth and expansion of its carrier and partner network. Assured Allies develops technology and services to predict and shift the aging trajectory using a patent-pending method and a proprietary aging score. The company offers the Age Assured program and aims to combine wellness with financial products to make longevity financially sustainable. It provides evidence-based interventions to reduce the risk of age-related decline and help people get the most out of life. Assured Allies was founded in 2018 and is based in Boston, MA and Tel Aviv, Israel. The founding team includes CEO Roee Nahir and Chief Product Officer Afik Gal, MD. The company plans to continue developing new aging innovations and to accelerate delivery of its Age Assured program.

Participated · Series B · Oct 2022

NorthOne is a New York-based challenger bank founded in 2016 that provides digital banking and financial tools tailored to small business owners such as barbers, mechanics and local restaurants. Its product roadmap extends beyond deposits to connect the data layer between accounting, receivables, payables, lending, payroll and the bank account ledger. The company replatformed onto The Bancorp Bank in 2021 and accepts cash deposits through partners like Walmart, 7‑11 and OfficeMax. Over the last 12 months NorthOne reported revenue growth of roughly 4x–5x, with customer growth in line with revenue; the majority of its customers have fewer than 10 employees. It has about 75 employees and says it will add staff programmatically as it builds new software layers and products. NorthOne markets through in-person events and partnerships (e.g., Profit First) in addition to online leads. NorthOne operates a mobile-first banking platform that connects to the financial tools companies use, provides insight into business financial health, and automates management tasks. The platform was launched in August in partnership with Boston-based Radius Bank and delivers banking functionalities such as wires, mobile check deposit, and cash deposits through its mobile app. NorthOne’s platform is API-enabled, allowing third-party developers to build applications and services around the product. The company says the idea originated in 2016 to act as the finance department small businesses might not otherwise be able to afford. NorthOne has offices in Toronto, Boston, and New York. Proceeds from the recent round will be used to develop a customer acquisition strategy and grow the team. NorthOne is building a mobile-first, API-enabled banking platform that provides bank accounts and a mobile app for small businesses, startups and freelancers. The product connects to existing financial management tools, offers real-time visibility into financial health and automates time-consuming financial tasks. More than 3,000 businesses had signed up for NorthOne accounts ahead of the platform’s launch. The company planned a late-2018 launch and intended to use new capital to finish development. NorthOne planned to expand its team from 5 to 15 employees using the seed proceeds. The company is led by co-founder and CEO Eytan Bensoussan and is based in Toronto, Canada.

Participated · Series C · Sep 2022

Carbyne builds a cloud-native APEX platform that embeds AI into 911 call handling, dispatch, resource coordination, and emergency decision-making. Its AI Suite is integrated across the platform rather than as bolt-on tools, trained on proprietary datasets generated from millions of emergency interactions. Over the past year the company reported triple-digit growth, including +477% year‑over‑year growth in APEX ARR and a +105% increase in APEX platform customers. Carbyne is deployed at nearly 300 sites worldwide across 23 U.S. states and six countries, with more than 7,000 calltakers using its platform. The company processes over 250 million data points annually and reports 99.999% call handling uptime. Carbyne plans to use new capital to expand R&D and engineering, deepen AI capabilities, scale operations globally, and pursue strategic partnerships and integrations. Carbyne provides cloud-native solutions for emergency response centers, enabling emergency contact centers and select enterprises to connect with callers and connected devices via secure channels without requiring a consumer app. Its unified platform delivers live, actionable data—including video, photos, geolocation—and AI-based features to streamline operations and improve transparency. The company offers Carbyne APEX, an i3-compliant unified emergency call management solution that consolidates AI and rich media data for call takers, and Carbyne Universe, an OTT solution that delivers AI-based and rich media functionality without disrupting existing contracts or infrastructure. Carbyne intends to use the new investment to expand operations and development efforts. Led by CEO Amir Elichai and based in New York City, the company is positioning its offerings for resale through AT&T. Carbyne provides cloud-based systems used by emergency services to handle medical, public-safety, transportation and other urgent calls, including its APEX platform used by customers such as the city of New Orleans. Its technology is installed in emergency response services that cover about 400 million people and handles roughly 150 million 911 calls annually, and the company says it is on track to cover 1 billion people by 2024. Carbyne aims to make contact-center workers more effective and less stressed by investing in tools like sentiment analysis and trauma detection and by capturing richer data from callers. The company plans to expand in the U.S., establish a partner program to pursue global opportunities (it does not sell directly), and increase R&D investment. Financially, Carbyne grew revenues 400% in the last year and has raised $56 million in a Series C that values the company around $400 million. The startup was founded in Israel (R&D remains there) and is now headquartered in New York; it is primarily active in the U.S. Carbyne provides a unified, cloud-native platform that enables emergency communication centers, first responders, citizens and governments to share live actionable data to improve operational efficiency and save lives. The company is expanding its cloud-native platform into the emergency health services market and introducing an instantly deployable platform for unified flow between callers, health-related call centers, first responders, nurses and hospitals. Carbyne plans to work with Global Medical Response to develop interactive communication solutions for health and medical sectors and to build new dedicated domestic resources. To scale operations in North America, Carbyne will relocate CTO and co-founder Alex Dizengoff from Tel Aviv to the United States to grow a North American R&D center. Global Medical Response’s COO Edward Van Horne will join Carbyne’s board of directors as part of the collaboration. Financially, the company has raised a total of $73 million since its launch in 2015. Carbyne offers a cloud-based platform for emergency services that surfaces richer caller data (location, video) and enables remote telemedicine to accelerate 911 and EMS responses. Its technology no longer requires users to install an app, having integrated third-party location services to connect callers directly. The company partners with public-health providers and firms such as CentralSquare and Global Medical Response and says it is on target to cover about 90% of the U.S. market. Usage and adoption grew strongly during the pandemic: Carbyne served 250 million people before COVID and now covers roughly 400 million people, launching a new implementation every 10 days since March. In the last nine months it provided about 155 million location points and 1.3 million minutes of video; revenues doubled starting in Q2 and then grew 160% in Q3 and Q4. Carbyne aims to serve some 1.5 billion people by 2023 as it expands its technology and market footprint.

Participated · Series A · Jul 2021

Sweetch is an Israeli company that builds an AI-driven behavior-change app which analyzes smartphone “lifeprint” data to deliver hyper-personalized, emotionally intelligent reminders. The app times messages and modulates tone to increase the likelihood users follow clinical advice, and is distributed via partnerships with healthcare organizations, pharma, payers and providers rather than as an open app. Sweetch reports "tens of thousands of users" and about 45% of patients remain active after 24 months. In a 55-person prediabetes trial run at two Johns Hopkins Clinical Research Network sites, participants who completed the three-month study increased physical activity by an average of 2.8 MET-hours, lost ~1.6 kg, and reduced A1c by ~0.1%. The company has received NIH grant support to continue testing against gold-standard interventions and plans upcoming randomized controlled trials. Sweetch says it will use the Series A proceeds to expand into the U.S. and Brazil, grow its user base, and further tailor recommendations for additional conditions. Sweetch offers a patent-pending mobile app that assesses individuals' diabetes risk with a conversion time horizon and uses algorithms to guide users to the key objectives of the Diabetes Prevention Program. The product is intended for people at risk of developing diabetes or those who may be undiagnosed. Sweetch aligns its guidance with the clinically validated diet and exercise regimen associated with the Diabetes Prevention Program. The company planned to participate in a pilot study at Johns Hopkins Medicine in the first quarter of the year. The recent financing will support Sweetch's ambition to go to market in the U.S. and to be prescribed by doctors there, leveraging the Centers for Medicare and Medicaid decision to provide reimbursement for DPP participants. Leadership includes CEO Dana Chanan, CMO and business development lead Dr. Yossi Bahagon, and CTO Dan Lichtenfeld.